Kathy Baker’s Post

March is Colorectal Cancer Awareness Month and there’s good and bad news when it comes to the third most common cancer diagnosed in the U.S. In fact, according to a new American Cancer Society (ACS) study, the number of people under 55 newly diagnosed with colorectal cancer has nearly doubled since 1995 despite this age group shrinking in the overall population by more than 10%. That’s why both ACS and the U.S. Preventive Services Task Force have issued new recommendations for people at average risk of colorectal cancer to start regular screening at age 45. This can be done either with a sensitive test that looks for signs of cancer in a person’s stool (a stool-based test), or with an exam that looks at the colon and rectum called a colonoscopy. Individuals with a family history of colorectal cancer may need to undergo screening at age 40 or even earlier. Fortunately, the new screening guidelines and the wide adoption of colonoscopies is saving lives! #coloncancer #coloncancerawareness

Cancer: from the fear of death to a stable disease ? Or is it that the advances in cancer treatment are not being seen by the general public and such creates fear and anxiety when being faced with such diagnosis… “Our fear of cancer has not caught up to the progress medicine has made” in recent decades. “As many as two-thirds of the nearly 200 cancers can [now] be treated as chronic conditions or cured outright, but we don’t believe that.” As a result, there are what too many “fear-ectomies” — medical unnecessary surgeries such as prostatectomies and radiation for asymptomatic, slow-growing prostate cancers and full mastectomies for breast ductal cancer that hasn’t spread and often won’t. In both those cases, experts say active surveillance with periodic follow-ups is a good approach. https://lnkd.in/e-d9CVRB

Patients are at the centre of everything ALLG does as we work towards better treatments, better lives and potentially, a cure for blood cancer.   Feedback and insights from our ALLG trial participants and patients with blood cancer are vital to our clinician researchers in developing and undertaking our clinical trial research. By sharing their lived experience with blood cancer, patients provide researchers with their invaluable perspective and ensure that the patient voice is incorporated into all aspects of our clinical trials.   Our Consumer Representative Panel is a key part of this process, providing insights into the patient experience and assisting our researchers with patient-centred reviews of our clinical trials and the relevancy of trial participant information to ensure that patient priorities are considered. The involvement and perspective of our Consumer Representative Panel are essential, and we greatly appreciate their contributions to our blood cancer research. If you’d like to hear more about our Consumer Representative Panel and their survivor stories, visit https://lnkd.in/g7ymAkRH. Or, if you’re interested in becoming a Consumer Representative, we invite you to find out more at allg.org.au.   Pictured L-R: John Stubbs, Pam K, Anne Hodgson, Emma Priest, Steve Towell & Chris Kershaw #ALLG #ALLGtrials #bettertreatmentsbetterlives #clinicaltrials   #bloodcancer #bloodcancerawareness #bloodcancercure #bloodcancers #haematology #haematologyresearch #leukaemiaandlymphoma #myeloma #myelomaawareness

🌸#October is Breast Cancer Awareness Month 👉#Understanding Hereditary Breast Cancer: Myths vs. Facts 📣 #Hereditary breast cancer is often misunderstood, leading to several myths that can create confusion: 🧬 #Myth 1: If no one in your family had breast cancer, you’re not at risk. Fact: Many with hereditary breast cancer have no known family history. 🧬 #Myth 2: Only women need to worry about hereditary breast cancer. #Fact: #Men can carry #BRCA mutations too, increasing their risk for cancers. 🧬 #Myth 3: A #BRCA mutation guarantees you’ll develop breast cancer. #Fact: While it increases your risk, it doesn’t guarantee a diagnosis. 📀Watch this video by our #Genetic #Counseling Team member Shalini Satish Kumar to explore various myths surrounding breast cancer. Understanding your genetic risk through testing, like #BRCA1 and #BRCA2 screening, can empower you with the right information and preventive measures. At 4baseCare, we’re here to guide you through this journey with #precision and #care. A big thank you to Divya Udyawar Uchil and her team for giving us valuable insights into the possibilities of #Genetic #Testing in #Cancer Treatment ! #BreastCancerAwareness #HereditaryCancer #GeneticTesting #BRCA #PrecisionOncology #4baseCare

𝗧𝗲𝘀𝘁𝗶𝗰𝘂𝗹𝗮𝗿 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝘀 𝗮 𝘂𝗻𝗶𝗾𝘂𝗲 𝗰𝗮𝘀𝗲 𝘄𝗵𝗲𝗻 𝗶𝘁 𝗰𝗼𝗺𝗲𝘀 𝘁𝗼 𝗮𝗴𝗲 𝗮𝘁 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀. In Belgium, 36% of testicular cancer cases are diagnosed in men in their thirties—this sharply contrasts with cancers in general, where only 2% of diagnoses occur in this age group. The 𝗺𝗲𝗱𝗶𝗮𝗻 𝗮𝗴𝗲 𝗳𝗼𝗿 𝘁𝗲𝘀𝘁𝗶𝗰𝘂𝗹𝗮𝗿 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝘀 𝗷𝘂𝘀𝘁 𝟯𝟱 𝘆𝗲𝗮𝗿𝘀, and over 80% of cases are found in men between 20 and 49. For cancers overall, the median age at diagnosis in men is 70 years. Each year, over 400 men in Belgium are diagnosed with testicular cancer. While incidence rates are rising, the positive news is that Belgium has a 𝟭𝟬-𝘆𝗲𝗮𝗿 𝗻𝗲𝘁 𝘀𝘂𝗿𝘃𝗶𝘃𝗮𝗹 𝗿𝗮𝘁𝗲 𝗼𝗳 𝟵𝟲% for this cancer. 💪 Find out more in our brand-new 𝗖𝗮𝗻𝗰𝗲𝗿 𝗙𝗮𝗰𝘁 𝗦𝗵𝗲𝗲𝘁: https://lnkd.in/erZJZ25P #CancerFactThursday #CancerRegistration #AYA #MensHealth

March is Colorectal Cancer Awareness Month. Colorectal cancer (CRC) is the second leading cause of cancer death in the US, behind only lung cancer. The National Cancer Institute (NCI) estimates that 153,020 people in the US received a CRC diagnosis in 2023, and approximately 52,550 died of it. In fact, CRC is now the #1 cancer killer among men under 50, and #2 for women under 50, just behind breast cancer, according to a recent American Cancer Society report. CRC awareness is important because many cases are preventable. Screening by colonoscopy can prevent this cancer by finding and removing precancerous polyps and can also detect the cancer at early stages, when treatment is more likely to be successful. And today, March 1, is #DressInBlueDay! By wearing blue, you bring awareness to this disease and support and honor all who are impacted by colorectal cancer. Let’s come together to raise awareness, share stories, ensure our voices are heard, and make a difference. #colorectalawarenessmonth #dressinblueday #getscreened #nevertooyoung #cancerawareness #earlydetectionsaveslives

I'm incredibly excited to let you know that I received a proclamation that October 15th is Lobular Breast Cancer Awareness Day from the State of Connecticut - Office of the Governor Ned Lamont who has officially declared October 15th as the first-ever Global Lobular Breast Cancer Awareness Day 👏 👏 👏 👏 👏 🦞 🦞🦞🦞🦞 🙏 🙏 🙏 🙏 🙏 Invasive lobular carcinoma (ILC), also known as lobular breast cancer, comprises 15% of all breast cancer diagnoses. Despite this incidence, there has been a lack of attention paid to the disease and a lack of funding for scientific research. Moreover, lobular breast cancer is notoriously sneaky, or insidious as I prefer to call it, and even more so if you have dense breasts like me. Many people are diagnosed at stage 4 before this type of cancer is detected. My lobular was 10.5 cm with smaller masses in my other breast and spread to the lymph nodes. It was only detected on an MRI after multiple mammograms and Ultrasounds so please be vigilant. Please share our posts to help spread the word and read more here: https://lnkd.in/eD6Rv5d6 #lobularbreastcancer #BreastCancerAwareness #BreastCancer #WomensHealth #learnaboutlobular #LobMob #NotAlwaysALump #missedonmammogram #DenseBreasts Lobular Breast Cancer Alliance Inc.

🌸#October is Breast Cancer Awareness Month 👉#Understanding Hereditary Breast Cancer: Myths vs. Facts 📣 #Hereditary breast cancer is often misunderstood, leading to several myths that can create confusion: 🧬 #Myth 1: If no one in your family had breast cancer, you’re not at risk. Fact: Many with hereditary breast cancer have no known family history. 🧬 #Myth 2: Only women need to worry about hereditary breast cancer. #Fact: #Men can carry #BRCA mutations too, increasing their risk for cancers. 🧬 #Myth 3: A #BRCA mutation guarantees you’ll develop breast cancer. #Fact: While it increases your risk, it doesn’t guarantee a diagnosis. 📀Watch this video by our #Genetic #Counseling Team member Shalini Satish Kumar to explore various myths surrounding breast cancer. Understanding your genetic risk through testing, like #BRCA1 and #BRCA2 screening, can empower you with the right information and preventive measures. At 4baseCare, we’re here to guide you through this journey with #precision and #care. A big thank you to Divya Udyawar Uchil and her team for giving us valuable insights into the possibilities of #Genetic #Testing in #Cancer Treatment ! #BreastCancerAwareness #HereditaryCancer #GeneticTesting #BRCA #PrecisionOncology #4baseCare

Understanding Tumor Markers is key to refining cancer treatment strategies. Dive into this topic with Dr. Carlos Bautista on The Beljanski Cancer Talk Show. Discover the significance of tests like PSAs and CEA in our latest episode, 'How To Rediscover Hope Through Alternative Cancer Treatments.' Don't miss out—join the conversation and gain new perspectives in oncology care. Discover Dr. Bautista's effective approach to cancer treatment at Immunity Therapy Center, specializing in alternative medicine and natural cancer therapy for a more efficient, less invasive option. Request a free consultation today and take the first step towards wellness. Visit https://lnkd.in/e-eAK4C3 for more information. Sign up and be one of the first few to know when the next episode releases PLUS get a FREE audiobook chapter of Sylvie’s award-winning book, "Winning The War On Cancer: The Epic Journey Towards a Natural Cure"! 👉 https://lnkd.in/epX5Ncr6 #Oncology #TumorMarkers #CancerCare #medicalresearch #cancerawareness

The latest edition of ALLG News is now available! Download a copy at https://lnkd.in/e4zt-jDk to read about Blood Cancer Awareness Month, its importance of raising awareness of blood cancer and the role of clinical trial research in improving treatments, survival rates and quality of life for patients. You can also read about our impactful international collaborative trials, hear from patients who have participated in ALLG clinical trials, and see ‘behind the trials’ at how ALLG drives new research to support better treatments and outcomes for blood cancer. ALLG is at the forefront of blood cancer research, with our 75 + current clinical trials investigating new, innovative treatments for leukaemia, lymphoma, myeloma and other blood cancers across Australia and New Zealand. Stay up to date with ALLG’s research news and impact by subscribing to ALLG News at https://lnkd.in/gXbmHTpF. #ALLG #ALLGtrials #bettertreatmentsbetterlives #clinicaltrials   #bloodcancer #bloodcancerawareness #bloodcancercure #bloodcancers #haematology #haematologyresearch #leukaemiaandlymphoma #myeloma #myelomaawareness